Stay updated on ERADICATE-HF: Clinical Trial in HFpEF and HFrEF
Sign up to get notified when there's something new on the ERADICATE-HF: Clinical Trial in HFpEF and HFrEF page.

Latest updates to the ERADICATE-HF: Clinical Trial in HFpEF and HFrEF page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe ERADICATE-HF study record is available, with details about its ertugliflozin-versus-placebo design, participants, outcomes, investigators, and study documents. It is marked completed and no longer recruiting.SummaryDifference57%

- Check15 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner announces NIH website updates and says the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check36 days agoChange DetectedThe site footer revision identifier changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study content, indicating restricted access to the page. The surrounding site chrome remains, but no study details are visible.SummaryDifference20%

Stay in the know with updates to ERADICATE-HF: Clinical Trial in HFpEF and HFrEF
Enter your email address, and we'll notify you when there's something new on the ERADICATE-HF: Clinical Trial in HFpEF and HFrEF page.